Mopec Group, headquartered in Madison Heights, Michigan, has established itself as a critical player in the pathology and anatomy fields since its inception in 1992. The company provides a comprehensive suite of branded equipment, consumables, and services essential for anatomic pathology and various laboratory end-markets. Mopec’s commitment is deeply rooted in empowering healthcare professionals with tools and solutions that advance diagnostic accuracy, safety, research, education, and ultimately, patient care.
Francis X. Dirksmeier, CEO of Mopec Group, expressed enthusiasm about the partnership, stating, “Joining forces with Waud Capital Partners LLC marks an exciting new chapter for Mopec. Their investment and expertise will significantly enhance our capabilities, particularly in innovation and growth, allowing us to deliver even greater value to our customers. Waud Capital shares our mission to enrich life by providing the foundational tools for advancing disease treatment. We are eager to build upon our current success and explore new avenues for growth together.”
Waud Capital Partners LLC has appointed Brad Staley as the Executive Chairman of Mopec Group’s Board of Directors. Staley, an Executive Partner at Waud Capital, brings over 25 years of experience in healthcare and technology, with a strong background in specialty distribution, products, and services. His expertise in scaling organizations through both organic growth and strategic acquisitions will be invaluable to Mopec. Previously, Staley served as CEO of Advancing Eyecare, where he demonstrated his ability to drive significant market expansion and operational excellence.
“Mopec is a recognized leader in its sector with a strong brand reputation,” commented Mr. Staley. “I am honored to support Fran and the Mopec leadership team in their mission to become the definitive solutions provider for pathology and lab markets. The foundation is strong, and the potential for future growth is substantial.”
Mike Lehman, Principal at Waud Capital Partners LLC, further elaborated on the strategic rationale behind the acquisition. “The increasing prevalence of diseases and the growing importance of precision medicine are driving significant demand for partners who can offer comprehensive, value-added solutions like Mopec. Their differentiated approach and commitment to long-term partnerships with pathology and lab customers are perfectly aligned with market needs. We are excited to collaborate with the Mopec team to strategically expand their offerings in equipment, consumables, and services.”
Kyle Lattner, Partner at Waud Capital Partners LLC, highlighted the broader investment strategy. “This investment in Mopec is a cornerstone of our Medical Device & Supply Services campaign, which we initiated in partnership with Brad Staley. Mopec represents an ideal opportunity within this campaign, and we are thrilled to partner with Fran and his team. This collaboration exemplifies Waud Capital’s investment philosophy of partnering with exceptional executive talent in sectors where we have deep conviction and expertise.”
About Mopec Group
Mopec Group is a vertically integrated manufacturer and supplier of high-quality equipment, consumables, and services for anatomic and forensic pathology. Founded in 1992, Mopec is dedicated to innovation, engineering excellence, and delivering outcome-focused solutions. The company’s mission is to elevate pathology by providing specialized solutions to hospitals, universities, morgues, and various other markets. For more information, please visit www.mopec.com.
About Waud Capital Partners LLC
Waud Capital Partners LLC is a growth-oriented private equity firm with over 30 years of experience in partnering with management teams to build leading companies in the healthcare and software & technology sectors. Since 1993, Waud Capital has completed over 460 investments, demonstrating a consistent track record of success. The firm is based in Chicago and is committed to fostering growth and innovation within its portfolio companies. For more information on Waud Capital Partners LLC, visit www.waudcapital.com.
For investment inquiries, please contact Kyle Lattner, Partner, at [email protected]. For business development matters, contact Phil Olson, Partner, at [email protected]. Investor relations inquiries can be directed to Jessica Schmitt, Head of Investor Relations, at [email protected].
